ondansetron 4 mg
1 INDICATIONS AND USAGE Ondansetron orally disintegrating tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron orally disintegrating tablets also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron orally disintegrating tablets are a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . (1) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. (1) nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. (1) postoperative nausea and/or vomiting. (1)
aurobindo pharma limited
ROUND WHITE E 5
E 5 ROUND WHITE
Related Pills
ondansetron 4 mg
aurobindo pharma limited
ondansetron 4 mg
aurobindo pharma limited
amiloride hydrochloride tablet
sigmapharm laboratories, llc
BZP hydrochloride 5 MG Oral Tablet
Eon Labs, Inc.
oxycodone hydrochloride tablet
epic pharma, llc
oxycodone hydrochloride tablet
epic pharma, llc
Selegiline Hydrochloride selegiline hydrochloride 5 MG Oral Tablet
Mylan Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
ONDANSETRON Orally Disintegrating Tablets USP, 4 mg are white to off-white, round tablets debossed with ‘5’ on one side and ‘E’ on the other side with an embossed circular edge. Bottles of 30 NDC 65862-390-30 Bottles of 100 NDC 65862-390-02 Bottles of 500 NDC 65862-390-05 Bottles of 10,000 NDC 65862-390-19 3 x 10 Unit-dose Tablets NDC 65862-390-10
ONDANSETRON Orally Disintegrating Tablets USP, 8 mg are white to off-white, round tablets debossed with ‘7’ on one side and ‘E’ on the other side with an embossed circular edge. Bottles of 30 NDC 65862-391-30 Bottles of 100 NDC 65862-391-02 Bottles of 500 NDC 65862-391-05 Bottles of 6,000 NDC 65862-391-66 1 x 10 Unit-dose Tablets NDC 65862-391-01 3 x 10 Unit-dose Tablets NDC 65862-391-10 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP.
More pills like ROUND E 5